Rüdiger E. Port

1.3k total citations · 1 hit paper
21 papers, 1.0k citations indexed

About

Rüdiger E. Port is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Materials Chemistry. According to data from OpenAlex, Rüdiger E. Port has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Oncology and 5 papers in Materials Chemistry. Recurrent topics in Rüdiger E. Port's work include Advanced MRI Techniques and Applications (6 papers), Lanthanide and Transition Metal Complexes (5 papers) and MRI in cancer diagnosis (4 papers). Rüdiger E. Port is often cited by papers focused on Advanced MRI Techniques and Applications (6 papers), Lanthanide and Transition Metal Complexes (5 papers) and MRI in cancer diagnosis (4 papers). Rüdiger E. Port collaborates with scholars based in Germany, Sweden and Netherlands. Rüdiger E. Port's co-authors include Wolfhard Semmler, Gunnar Brix, Lothar R. Schad, G. Layer, Walter J. Lorenz, Werner Kunz, William E. Hull, Richard Herrmann, Mats O. Karlsson and Lewis B. Sheiner and has published in prestigious journals such as Environmental Health Perspectives, Anesthesiology and Carcinogenesis.

In The Last Decade

Rüdiger E. Port

21 papers receiving 1.0k citations

Hit Papers

Pharmacokinetic Parameters in CNS Gd-DTPA Enhanced MR Ima... 1991 2026 2002 2014 1991 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pharmacokinetic Parameters in CNS Gd-DTPA Enhanced MR Imaging
    1991 550 citations Gunnar Brix, Wolfhard Semmler et al. Journal of Computer Assisted Tomography profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rüdiger E. Port Germany 13 590 202 177 108 107 21 1.0k
A. Veyre France 23 888 1.5× 288 1.4× 430 2.4× 21 0.2× 225 2.1× 110 1.6k
Romaric Loffroy France 21 371 0.6× 112 0.6× 320 1.8× 62 0.6× 291 2.7× 71 1.8k
K. A. Krohn United States 22 1.2k 2.0× 234 1.2× 228 1.3× 45 0.4× 301 2.8× 59 1.8k
J. M. Link United States 12 392 0.7× 113 0.6× 66 0.4× 18 0.2× 74 0.7× 22 653
A Piffanelli Italy 22 493 0.8× 362 1.8× 277 1.6× 19 0.2× 204 1.9× 90 1.4k
Toshihiko Hara Japan 21 1.1k 1.9× 151 0.7× 228 1.3× 81 0.8× 734 6.9× 76 2.0k
Balaji Agoram United States 18 154 0.3× 306 1.5× 331 1.9× 47 0.4× 52 0.5× 46 1.3k
Ajay Bhargava United States 19 94 0.2× 247 1.2× 516 2.9× 30 0.3× 170 1.6× 47 1.1k
Jean‐Luc Moretti France 25 1.1k 1.8× 488 2.4× 239 1.4× 29 0.3× 421 3.9× 73 1.9k
Ofer Kaplan Israel 24 370 0.6× 577 2.9× 567 3.2× 63 0.6× 197 1.8× 72 2.1k

Countries citing papers authored by Rüdiger E. Port

Since Specialization
Citations

This map shows the geographic impact of Rüdiger E. Port's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rüdiger E. Port with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rüdiger E. Port more than expected).

Fields of papers citing papers by Rüdiger E. Port

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rüdiger E. Port. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rüdiger E. Port. The network helps show where Rüdiger E. Port may publish in the future.

Co-authorship network of co-authors of Rüdiger E. Port

This figure shows the co-authorship network connecting the top 25 collaborators of Rüdiger E. Port. A scholar is included among the top collaborators of Rüdiger E. Port based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rüdiger E. Port. Rüdiger E. Port is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferl, Gregory Z. & Rüdiger E. Port. (2012). Quantification of Antiangiogenic and Antivascular Drug Activity by Kinetic Analysis of DCE-MRI Data. Clinical Pharmacology & Therapeutics. 92(1). 118–124. 13 indexed citations
2.
McSheehy, Paul M.J., Rüdiger E. Port, Luís Monteiro Rodrigues, et al.. (2004). Investigations in vivo of the effects of carbogen breathing on 5-fluorouracil pharmacokinetics and physiology of solid rodent tumours. Cancer Chemotherapy and Pharmacology. 55(2). 117–128. 10 indexed citations
3.
Port, Rüdiger E.. (2004). Non-parametric mixed effects modeling with NPAG: hematopoietic response to erythropoietin in children. International Journal of Clinical Pharmacology and Therapeutics. 42(3). 185–186. 1 indexed citations
4.
Port, Rüdiger E., et al.. (2003). The influence of liver metastases on the pharmacokinetics of doxorubicin a population-based pharmacokinetic project of the CESAR-APOH. International Journal of Clinical Pharmacology and Therapeutics. 41(12). 598–599. 6 indexed citations
5.
Kissel, J. T., Rüdiger E. Port, J. Zaers, et al.. (1999). Noninvasive determination of the arterial input function of an anticancer drug from dynamic PET scans using the population approach. Medical Physics. 26(4). 609–615. 11 indexed citations
6.
Bouillon, Thomas, Daniela Kietzmann, Rüdiger E. Port, Ingolf Meineke, & Andreas Hoeft. (1999). Population Pharmacokinetics of Piritramide in Surgical Patients . Anesthesiology. 90(1). 7–15. 27 indexed citations
7.
Becker, Markus, et al.. (1998). Monitoring Local Disposition Kinetics of Carboplatinin Vivoafter Subcutaneous Injection in Rats by Means of195Pt NMR. Journal of Magnetic Resonance. 133(1). 115–122. 15 indexed citations
8.
9.
Karlsson, Mats O., Rüdiger E. Port, Mark J. Ratain, & Lewis B. Sheiner. (1995). A population model for the leukopenic effect of etoposide*. Clinical Pharmacology & Therapeutics. 57(3). 325–334. 54 indexed citations
10.
Port, Rüdiger E., et al.. (1994). Influence of Tetrachlorodecaoxide (Ryoxon®) on the Development of Leukemia after Total-Body Gamma-Irradiation. Oncology. 51(6). 510–514. 3 indexed citations
11.
Port, Rüdiger E., et al.. (1994). Pharmacokinetic analysis of sparse in vivo NMR spectroscopy data using relative parameters and the population approach. European Journal of Clinical Pharmacology. 47(2). 187–93. 8 indexed citations
12.
Port, Rüdiger E., et al.. (1991). Relative Importance of Dose, Body Surface Area, Sex, and Age for 5-Fluorouracil Clearance. Oncology. 48(4). 277–281. 52 indexed citations
13.
Brix, Gunnar, Wolfhard Semmler, Rüdiger E. Port, et al.. (1991). Pharmacokinetic Parameters in CNS Gd-DTPA Enhanced MR Imaging. Journal of Computer Assisted Tomography. 15(4). 621–628. 550 indexed citations breakdown →
14.
Port, Rüdiger E., Peter Bachert, & Wolfhard Semmler. (1991). Kinetic modeling of in vivo—nuclear magnetic resonance spectroscopy data: 5–Fluorouracil in liver and liver tumors. Clinical Pharmacology & Therapeutics. 49(5). 497–505. 23 indexed citations
15.
Port, Rüdiger E., Lutz Edler, Richard Herrmann, & U. Feldmann. (1991). Pharmacokinetics of 5-Fluorouracil After Short Systemic Infusion. Therapeutic Drug Monitoring. 13(2). 96–102. 13 indexed citations
16.
Port, Rüdiger E., Ludwig G. Strauss, & John H. Clorius. (1989). Positronen-Emissions-Tomographie nach Kurzinfusion von 5-[<sup>18</sup>F]Uracil: Lineares Modell für die Kinetik der <sup>18</sup>F-Radioaktivität in Tumoren. Oncology Research and Treatment. 12(1). 51–52. 2 indexed citations
17.
18.
Hull, William E., et al.. (1988). Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment.. PubMed. 48(6). 1680–8. 111 indexed citations
19.
Herrmann, Richard, et al.. (1985). The effect of methotrexate pretreatment on 5-fluorouracil kinetics in sarcoma 180 in Vivo. European Journal of Cancer and Clinical Oncology. 21(6). 753–758. 7 indexed citations
20.
Kunz, Heinz W., et al.. (1983). Quantitative aspects of chemical carcinogenesis and tumor promotion in liver.. Environmental Health Perspectives. 50. 113–122. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Veyre Breakdown of academic impact, for papers by Romaric Loffroy Breakdown of academic impact, for papers by K. A. Krohn Breakdown of academic impact, for papers by J. M. Link Breakdown of academic impact, for papers by A Piffanelli Breakdown of academic impact, for papers by Toshihiko Hara Breakdown of academic impact, for papers by Balaji Agoram Breakdown of academic impact, for papers by Ajay Bhargava Breakdown of academic impact, for papers by Jean‐Luc Moretti Breakdown of academic impact, for papers by Ofer Kaplan
Rankless by CCL
2026